Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Smith

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
Leukemia & Lymphoma|January 1, 1994
Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequencesE Bayever, K M Haines, P L Iversen, et al.
Biochemistry|July 22, 1997
Structural and dynamical properties of a denatured protein. Heteronuclear 3D NMR experiments and theoretical simulations of lysozyme in 8 M ureaH Schwalbe, K M Fiebig, M Buck, et al.
Journal of Molecular Biology|February 12, 1998
NMR analysis of main-chain conformational preferences in an unfolded fibronectin-binding proteinC J Penkett, C Redfield, I Dodd, et al.
Biological Psychology|November 16, 1995
Properties of human affect induced by static color slides (IAPS): dimensional, categorical and electromyographic analysisW J Davis, M A Rahman, L J Smith, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1993
Intraventricular alpha interferon therapy for Rasmussen's syndromeB L Maria, D M Ringdahl, J P Mickle, et al.
Nature Structural Biology|May 1, 1994
Comparison of four independently determined structures of human recombinant interleukin-4L J Smith, C Redfield, R A Smith, et al.
Animals : an Open Access Journal From MDPI|October 16, 2024
The Effects of Onychectomy (Declawing) on Forearm and Leg Myology in a Kinkajou (<i>Potos flavus</i>)Lara L Martens, Reece A Brown, Ana Carolina Lourenço Faillace, et al.
Clinical Therapeutics|May 1, 1993
Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patientsJ A Miller, T Butler, R A Beveridge, et al.
Folding & Design|January 1, 1996
Native-like secondary structure in a peptide from the alpha-domain of hen lysozymeJ J Yang, B van den Berg, M Pitkeathly, et al.
British Journal of Pharmacology|December 28, 2018
Activation of RyR2 by class I kinase inhibitorsA D Chakraborty, L A Gonano, M L Munro, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
Leukemia & Lymphoma|January 1, 1994
Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequencesE Bayever, K M Haines, P L Iversen, et al.
Biochemistry|July 22, 1997
Structural and dynamical properties of a denatured protein. Heteronuclear 3D NMR experiments and theoretical simulations of lysozyme in 8 M ureaH Schwalbe, K M Fiebig, M Buck, et al.
Journal of Molecular Biology|February 12, 1998
NMR analysis of main-chain conformational preferences in an unfolded fibronectin-binding proteinC J Penkett, C Redfield, I Dodd, et al.
Biological Psychology|November 16, 1995
Properties of human affect induced by static color slides (IAPS): dimensional, categorical and electromyographic analysisW J Davis, M A Rahman, L J Smith, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1993
Intraventricular alpha interferon therapy for Rasmussen's syndromeB L Maria, D M Ringdahl, J P Mickle, et al.
Nature Structural Biology|May 1, 1994
Comparison of four independently determined structures of human recombinant interleukin-4L J Smith, C Redfield, R A Smith, et al.
Animals : an Open Access Journal From MDPI|October 16, 2024
The Effects of Onychectomy (Declawing) on Forearm and Leg Myology in a Kinkajou (<i>Potos flavus</i>)Lara L Martens, Reece A Brown, Ana Carolina Lourenço Faillace, et al.
Clinical Therapeutics|May 1, 1993
Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patientsJ A Miller, T Butler, R A Beveridge, et al.
Folding & Design|January 1, 1996
Native-like secondary structure in a peptide from the alpha-domain of hen lysozymeJ J Yang, B van den Berg, M Pitkeathly, et al.
British Journal of Pharmacology|December 28, 2018
Activation of RyR2 by class I kinase inhibitorsA D Chakraborty, L A Gonano, M L Munro, et al.
Pageof 29